APRI (Aprinoia Therapeutics) Total Operating Expense: $33.28 Mil (TTM As of Dec. 2023)


What is Aprinoia Therapeutics Total Operating Expense?

Aprinoia Therapeutics APRI Total Operating Expense is $33.28 Mil as of Dec. 2023.

Aprinoia Therapeutics's Total Operating Expense for the six months ended in Dec. 2023 was $17.51 Mil. Aprinoia Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $33.28 Mil.

Aprinoia Therapeutics Total Operating Expense Related Terms

Aprinoia Therapeutics Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Total Operating Expense Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Total Operating Expense
24.45 28.66 33.28

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Total Operating Expense 0.00 14.14 14.52 15.77 17.51

Aprinoia Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $33.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $33.28 Mil mean?
Aprinoia Therapeutics (APRI) has a Total Operating Expense of $33.28 Mil as of Dec. 2023. Total operating expense is the primary recurring expense associated with central operations. View historical data on Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Total Operating Expense too high?
Aprinoia Therapeutics' current Total Operating Expense is $33.28 Mil.
How does Aprinoia Therapeutics' Total Operating Expense compare to ?
Aprinoia Therapeutics' Total Operating Expense of $33.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Total Operating Expense is $33.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Total Operating Expense of $33.28 Mil. The current Total Operating Expense is $33.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Total Operating Expense is $33.28 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.